Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III adjuvant chemotherapy comparison in women with node-positive breast cancer
2005-004822-19Phase 3Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Oct 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gemcitabine, docetaxel, paclitaxel, doxorubicin and cyclophosphamide in breast cancer (3 arms), sponsored by Cancer Trials Ireland. Primary endpoint: Disease-free survival. Started Oct 2005; status: completed.
02
Drugs
gemcitabinedocetaxelpaclitaxeldoxorubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-004822-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004822-19.